|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Health Policy Problem Solver: Fumie Griegoover 8 years ago
Dealmaking in 2017: Striking a Balanceover 8 years ago
Beyond the Science: Commercial Implications From ASCO 2017almost 9 years ago
News Spotlight: Pharmaalmost 9 years ago
Pharma’s Marijuana Makeoveralmost 9 years ago
The 'Hear' and Now for Pharma and Social Mediaalmost 9 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abusealmost 9 years ago
Syncing Social Media With Value-Care Modelalmost 9 years ago
AI-based Social Listening as Aid to Pharmacovigilancealmost 9 years ago
Country Report: IndonesiaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
What Pharma Investors Should Expect in the Current Regulatory Environment
4
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
5